Centers for Disease Control and Prevention, “At a Glance: Diabetes: Disabling, Deadly, and on the Rise *2004,” available at: http://www.cdc.gov/nccdphp/aag/aag_ddt.htm, accessed on April 7, 2004.
American Diabetes Association, “Diabetes and Cardiovascular (Heart) Disease,” available at: http://www.diabetes.org/diabetesstatistics/heart-disease.jsp, accessed on April 7, 2004.
Garnt, P. J., Davies, J. A., “Cardiovascular Diseases and Diabetes,” 2002, In: Textbook of Diabetes, Pickup, J. C. et al. (Eds.), Blackwell Publishing, 3rd Edition.
American Diabetes Association, “Diabetes and Cardiovascular (Heart) Disease,” available at: http://www.diabetes.org/diabetesstatistics/heart-disease.jsp, accessed on April 7, 2004.
Piette, J. D., Heisler, M., Wagner, T. H., “Problems Paying out-of-Pocket Medication Costs Among Older Adults with Diabetes,” Diabetes Care, 27(2), 2004, pages 384–391.
Centers for Disease Control and Prevention, “At a Glance: Diabetes: Disabling, Deadly, and on the Rise 2004,” available at: http://www.cdc.gov/nccdphp/aag/aag_ddt.htm, accessed on April 7, 2004.
Centers for Disease Control and Prevention, “National Diabetes Fact Sheet: United States, November 2003,” available at: http://www.cdc.gov/diabetes/pubs/factsheet.htm, accessed on April 7, 2004.
National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Bethesda, MD: U. S. Department of Health and Human Services, National Institutes of Health, 2003.
National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Bethesda, MD: U. S. Department of Health and Human Services, National Institutes of Health, 2003.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, “Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, 26(1S), 2003, pages S5–S20.
Genuth, S., Alberti, K. G., Bennett, P., et al., “Follow-up Report on the Diagnosis of Diabetes Mellitus,” Diabetes Care, 26(11), 2003, pages 3160–3167.
King, H., Aubert, R. E., Herman, W. H., “Global Burden of Diabetes, 1995–2025: Prevalence, Numerical Estimates, and Projections,” Diabetes Care, 21(9), 1998, pages 1414–1431.
World Health Organization. “Diabetes Estimates and Projections,” available at: http://www.who.int/ncd/dia/databases4.htm, accessed on February 24, 2004.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, “Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, 26(1S), 2003, pages S5–S20.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, “Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, 26(1S), 2003, pages S5–20.
National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Bethesda, MD: U. S. Department of Health and Human Services, National Institutes of Health, 2003.
“Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, 27(1S), 2004, pages S5-S10.
Ovalle, F., Azziz, R., “Insulin Resistance, Polycystic Ovary Syndrome, and Type 2 Diabetes Mellitus,” Fertility and Sterility, 77(6), 2002, pages 1095–1105.
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., et al., “Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study,” Journal of Clinical Endocrinology and Metabolism, 83(9), 1998, pages 3078–3082.
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., et al., “Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study,” Journal of Clinical Endocrinology and Metabolism, 83(9), 1998, pages 3078–3082.
“Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, 27(1S), 2004, pages S5-S10.
Fagot-Campagna, A., Pettitt, D. J., Engelgau, M. M., et al., “Type 2 Diabetes Among North American Children and Adolescents: An Epidemiologic Review and a Public Health Perspective,” Journal of Pediatrics, 136(5), 2000, pages 664–672.
Michels, K. B., Solomon, C. G., Hu, F. B., et al., “Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses’ Health Study,” Diabetes Care, 26(6), 2003, pages 1752–1758.
National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Bethesda, MD: U. S. Department of Health and Human Services, National Institutes of Health, 2003.
National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Bethesda, MD: U. S. Department of Health and Human Services, National Institutes of Health, 2003.
DeFronzo, R. A., Bonadonna, R. C., Ferrannini, E., “Pathogenesis of NIDDM. A Balanced Overview,” Diabetes Care, 15(3), 1992, pages 318–368.
Barzilay, J. I., Freedland, E. S., “Inflammation and Its Relationship to Insulin Resistance, Type 2 Diabetes Mellitus, and Endothelial Dysfunction,” Metabolic Syndrome and Related Disorders, 1(1), 2003, pages 55–67.
Grundy, S. M., “Inflammation, Hypertension, and the Metabolic Syndrome,” Journal of the American Medical Association, 290(22), 2003, pages 3000–3002.
Caballero, A. E., “Endothelial Dysfunction in Obesity and Insulin Resistance: A Road to Diabetes and Heart Disease,” Obesity Research, 11 (11), 2003, pages 1278–1289.
Vernon, M. C., Mavropoulos, J., Transue, M., et al., “Clinical Experience of a Carbohydrate-Restricted Diet: Effect on Diabetes Mellitus,” Metabolic Syndrome and Related Disorders, 1 (3), 2003, pages 233–237.
Yancy, W. S., Vernon, M. C., Westman, E. C., “A Pilot Trial of a Low-Carbohydrate, Ketogenic Diet in Patients with Type 2 Diabetes,” Metabolic Syndrome and Related Disorders, 1(3), 2003, pages 239–243.
National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Bethesda, MD: U. S. Department of Health and Human Services, National Institutes of Health, 2003.
Harris, M. I., “Undiagnosed NIDDM: Clinical and Public Health Issues,” Diabetes Care, 16(4), 1993, pages 642–652.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, “Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, 26(1S), 2003, pages S5-S20.
Chan, J. M., Rimm, E. B., Colditz, G. A., et al., “Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men,” Diabetes Care, 17(9), 1994, pages 961–969.
Colditz, G. A., Willett, W. C., Rotnitzky, A., et al., “Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women,” Annals of Internal Medicine, 122(7), 1995, pages 481–486.
Pi-Sunyer, F. X., “The Obesity Epidemic: Pathophysiology and Consequences of Obesity,” Obesity Research, 10(2S), 2002, pages 97S-104S.
Burke, J. P., Williams, K., Narayan, K. M., et al., “A Population Perspective on Diabetes Prevention: Whom Should We Target for Preventing Weight Gain?” Diabetes Care, 26(7), 2003, pages 1999–2004.
National Heart, Lung, and Blood Institute, “Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Executive Summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults,” 1998.
Heiat, A. National Institutes of Health (NIH: the NIH Consensus Conference on Health Implications of Obesity in 1985); United States Department of Agriculture (the 1990 Department of Agriculture’s Dietary Guidelines for Americans); National Heart, Lung, and Blood Institute., “Impact of Age on Definition of Standards for Ideal Weight,” Preventive Cardiology, 6(2), 2003, pages 104–107.
Aronne, L. J., Segal, K. R., “Adiposity and Fat Distribution Outcome Measures: Assessment and Clinical Implications,” Obesity Research, 10(1S), 2002, pages 14S-21S.
Chan, J. M., Rimm, E. B., Colditz, G. A., et al., “Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men,” Diabetes Care, 17(9), 1994, pages 961–969.
Colditz, G. A., Willett, W. C., Rotnitzky, A., et al., “Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women,” Annals of Internal Medicine, 122(7), 1995, pages 481–486.
Colditz, G. A., Willett, W. C., Rotnitzky, A., et al., “Weight Gain as a Risk Factor for Clinical Diabetes Mellitus in Women,” Annals of Internal Medicine, 122(7), 1995, pages 481–486.
Chan, J. M., Rimm, E. B., Colditz, G. A., et al., “Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men,” Diabetes Care, 17(9), 1994, pages 961–969.
Seidell, J. C., Kahn, H. S., Williamson, D. F., et al., “Report from a Centers for Disease Control and Prevention Workshop on Use of Adult Anthropometry for Public Health and Primary Health Care,” American Journal of Clinical Nutrition, 73(1), 2001, pages 123–126.
Kahn, H. S., Valdez, R., “Metabolic Risks Identified by the Combination of Enlarged Waist and Elevated Triacylglycerol Concentration,” American Journal of Clinical Nutrition, 78(5), 2003, pages 928–934.
Janssen, I., Katzmarzyk, P. T., Ross, R., “Waist Circumference and Not Body Mass Index Explains Obesity-Related Health Risk,” American Journal of Clinical Nutrition, 79(3), 2004, pages 379–384.
Janssen, I., Katzmarzyk, P. T., Ross, R., “Waist Circumference and Not Body Mass Index Explains Obesity-Related Health Risk,” American Journal of Clinical Nutrition, 79(3), 2004, pages 379–384.
Wannamethee, S. G., Shaper, A. G., “Alcohol, Body Weight, and Weight Gain in Middle-Aged Men,” American Journal of Clinical Nutrition, 77(5), 2003, pages 1312–1317.
Bernstein, R. K., “Dr. Bernstein’s Diabetes Solution: The Complete Guide to Achieving Normal Blood Sugars Revised & Updated,” 2003, Little Brown & Company, Revised Edition, page 480.
Reaven, G. M., “Banting Lecture 1988. Role of Insulin Resistance in Human Disease,” Diabetes, 37(12), 1988, pages 1595–1607.
Calle, E. E., Thun, M. J., Petrelli, J. M., et al., “Body-Mass Index and Mortality in a Prospective Cohort of U. S. Adults,” New England Journal of Medicine, 341 ( 15), 1999, pages 1097–1105.
Arcaro, G., Cretti, A., Balzano, S., et al., “Insulin Causes Endothelial Dysfunction in Humans: Sites and Mechanisms,” Circulation, 105(5), 2002, pages 576–582.
Reaven, G. M., “Banting Lecture 1988. Role of Insulin Resistance in Human Disease,” Diabetes, 37( 12), 1988, pages 1595–1607.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, “Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),” Journal of the American Medical Association, 285( 19), 2001, pages 2486–2497.
Ford, E. S., Giles, W. H., “A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions,” Diabetes Care, 26(3), 2003, pages 575–581.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, “Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),” Journal of the American Medical Association, 285( 19), 2001, pages 2486–2497.
Ford, E. S., Giles, W. H., Dietz, W. H., “Prevalence of the Metabolic Syndrome Among US Adults: Findings from the Third National Health and Nutrition Examination Survey,” Journal of the American Medical Association, 287(3), 2002, pages 356–359.
Alberti, K. G., Zimmet, P. Z., “Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus Provisional Report of a WHO Consultation,” Diabetic Medicine, 15(7), 1998, pages 539–553.
Alberti, K. G., Zimmet, P. Z., “Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus Provisional Report of a WHO Consultation,” Diabetic Medicine, 15(7), 1998, pages 539–553.
Ford, E. S., Giles, W. H., “A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions,” Diabetes Care, 26(3), 2003, pages 575–581.
Alexander, C. M., Landsman, P. B., Teutsch, S. M., et al., “NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease among NHANES III Participants Age 50 Years and Older,” Diabetes, 52(5), 2003, pages 1210–1214.
Seidell, J. C., Kahn, H. S., Williamson, D. F., et al., “Report from a Centers for Disease Control and Prevention Workshop on Use of Adult Anthropometry for Public Health and Primary Health Care,” American Journal of Clinical Nutrition, 73(1), 2001, pages 123–126.
Kahn, H. S., Valdez, R., “Metabolic Risks Identified by the Combination of Enlarged Waist and Elevated Triacylglycerol Concentration,” American Journal of Clinical Nutrition, 78(5), 2003, pages 928–934.
Janssen, I., Katzmarzyk, P. T., Ross, R., “Waist Circumference and Not Body Mass Index Explains Obesity-Related Health Risk,” American Journal of Clinical Nutrition, 79(3), 2004, pages 379–384.
Aronne, L. J., Segal, K. R., “Adiposity and Fat Distribution Outcome Measures: Assessment and Clinical Implications,” Obesity Research, 10(1S), 2002, pages 14S-21S.
Pi-Sunyer, F. X., “The Obesity Epidemic: Pathophysiology and Consequences of Obesity,” Obesity Research, 10(2S), 2002, pages 97S-104S.
Ruderman, N., Chisholm, D., Pi-Sunyer, X., et al., “The Metabolically Obese, Normal-Weight Individual Revisited,” Diabetes, 47(5), 1998, pages 699–713.
Sattar, N., Gaw, A., Scherbakova, O., et al., “Metabolic Syndrome with and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study,” Circulation, 108(4), 2003, pages 414–419.
Hudgins, L. C., “Effect of High-Carbohydrate Feeding on Triglyceride and Saturated Fatty Acid Synthesis,” Proceedings of the Society for Experimental Biology and Medicine, 225(3), 2000, pages 178–183.
Hudgins, L. C., Hellerstein, M. K., Seidman, C. E., et al., “Relationship Between Carbohydrate-Induced Hypertriglyceridemia and Fatty Acid Synthesis in Lean and Obese Subjects,” Journal of Lipid Research, 41(4), 2000, pages 595–604.
American Heart Association, “Carbohydrates and Sugars,” available at: http://www.americanheart.org, accessed February 27, 2004.
Volek, J. S., Sharman, M. J., Love, D. M., et al., “Body Composition and Hormonal Responses to a Carbohydrate-Restricted Diet,” Metabolism: Clinical and Experimental, 51 (7), 2002, pages 864–870.
Layman, D. K., “The Role of Leucine in Weight Loss Diets and Glucose Homeostasis,” Journal of Nutrition, 133 (1), 2003, pages 261 S-267S.
Layman, D. K., Boileau, R. A., Erickson, D. J., et al., “A Reduced Ratio of Dietary Carbohydrate to Protein Improves Body Composition and Blood Lipid Profiles During Weight Loss in Adult Women,” Journal of Nutrition, 133(2), 2003, pages 411–417.
Westerterp-Plantenga, M. S., “The Significance of Protein in Food Intake and Body Weight Regulation,” Current Opinion in Clinical Nutrition and Metabolic Care, 6(6), 2003, pages 635–638.
Asztalos, B., Lefevre, M., Wong, L., et al., “Differential Response to Low-Fat Diet Between Low and Normal HDL-Cholesterol Subjects,” Journal of Lipid Research, 41(3), 2000, pages 321–328.
Aro, A., Pietinen, P., Valsta, L. M., et al., “Effects of Reduced-Fat Diets with Different Fatty Acid Compositions on Serum Lipoprotein Lipids and Apolipoproteins,” Public Health Nutrition, 1(2), 1998, pages 109–116.
Berglund, L., Oliver, E. H., Fontanez, N., et al., “HDL-Subpopulation Patterns in Response to Reductions in Dietary Total and Saturated Fat Intakes in Healthy Subjects,” American Journal of Clinical Nutrition, 70(6), 1999, pages 992–1000.
Brehm, B. J., Seeley, R. J., Daniels, S. R., et al., “A Randomized Trial Comparing a Very Low Carbohydrate Diet and a Calorie-Restricted Low Fat Diet on Body Weight and Cardiovascular Risk Factors in Healthy Women,” Journal of Clinical Endocrinology and Metabolism, 88(4), 2003, pages 1617–1623.
Foster, G. D., Wyatt, H. R., Hill, J. O., et al., “A Randomized Trial of a Low-Carbohydrate Diet for Obesity,” New England Journal of Medicine, 348(21), 2003, pages 2082–2090.
O’Brien, K. D., Brehm, B. J., Seeley, R. J., “Greater Reduction in Inflammatory Markers with Low Carbohydrate Diet Than with a Calorically Matched Low Fat Diet,” Presented at American Heart Association’s Scientific Sessions 2002 on Tuesday, November 19, 2002, Abstract ID: 117597.
Samaha, F. F., Iqbal, N., Seshadri, P., et al., “A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity,” New England Journal of Medicine, 348(21), 2003, pages 2074–2081.
Sharman, M. J., Kraemer, W. J., Love, D. M., et al., “A Ketogenic Diet Favorably Affects Serum Biomarkers for Cardiovascular Disease in Normal-Weight Men,” Journal of Nutrition, 132(7), 2002, pages 1879–1885.
Sondike, S. B., Copperman, N., Jacobson, M. S., “Effects of a Low-Carbohydrate Diet on Weight Loss and Cardiovascular Risk Factor in Overweight Adolescents,” Journal of Pediatrics, 142(3), 2003, pages 253–258.
Volek, J. S., Sharman, M. J., Gomez, A. L., et al., “An Isoenergetic Very Low Carbohydrate Diet Improves Serum HDL Cholesterol and Triacylglycerol Concentrations, the Total Cholesterol to HDL Cholesterol Ratio and Postprandial Pipemic Responses Compared with a Low Fat Diet in Normal Weight, Normolipidemic Women,” Journal of Nutrition, 133(9), 2003, pages 2756–2761.
Westman, E. C., Yancy, W. S., Edman, J. S., et al., “Effect of 6-Month Adherence to a Very Low Carbohydrate Diet Program,” American Journal of Medicine, 113 (1), 2002, pages 30–36.
Westman, E. C., Yancy, W. S., Jr., Guyton, J. S., “Effect of a Low Carbohydrate Ketogenic Diet Program on Fasting Lipid Subfractions,” Circulation, 106(19(SII)), 2002, page 727.
Chobanian, A. V., Bakris, G. L., Black, H. R., et al., “Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,” Hypertension, 42(6), 2003, pages 1206–1252.
Ford, E. S., Giles, W. H., “A Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions,” Diabetes Care, 26(3), 2003, pages 575–581.
Ridker, P. M., Morrow, D. A., “C-Reactive Protein, Inflammation, and Coronary Risk,” Cardiology Clinics, 21 (3), 2003, pages 315–325.
Reaven, G., “Syndrome X,” Current Treatment Options in Cardiovascular Medicine, 3 (4), 2001, pages 323–332.
Layman, D. K., Boileau, R. A., Erickson, D. J., et al., “A Reduced Ratio of Dietary Carbohydrate to Protein Improves Body Composition and Blood Lipid Profiles During Weight Loss in Adult Women,” Journal of Nutrition, 133(2), 2003, pages 411–417.
Volek, J. S., Sharman, M. J., Love, D. M., et al., “Body Composition and Hormonal Responses to a Carbohydrate-Restricted Diet,” Metabolism: Clinical and Experimental, 51(7), 2002, pages 864–870.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, “Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, 26(1S), 2003, pages S5-S20.
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, “Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus,” Diabetes Care, 26(1S), 2003, pages S5-S20.
National Institute of Diabetes and Digestive and Kidney Diseases, “Insulin Resistance and Pre-Diabetes,” November 2003, available at: http://www.diabetes.niddk.nih.gov/dm/pubs/insulinresistance/index.htm. , accessed on February 27, 2004.
American Diabetes Association, “Standards of Medical Care for Patients with Diabetes Mellitus,” Diabetes Care, 26(1S), 2003, pages S33-S50.
Dallo, F. J., Weller, S. C., “Effectiveness of Diabetes Mellitus Screening Recommendations,” Proceedings of the National Academy of Sciences of the United States of America, 100(18), 2003, pages 10574–10579.
Dallo, F. J., Weller, S. C., “Effectiveness of Diabetes Mellitus Screening Recommendations,” Proceedings of the National Academy of Sciences of the United States of America, 100(18), 2003, pages 10574–10579.
Bjornholt, J. V., Erikssen, G., Aaser, E., et al., “Fasting Blood Glucose: An Underestimated Risk Factor for Cardiovascular Death. Results from a 22-Year Follow-up of Healthy Nondiabetic Men,” Diabetes Care, 22(1), 1999, pages 45–49.
Saydah, S. H., Loria, C. M., Eberhardt, M. S., et al., “Subclinical States of Glucose Intolerance and Risk of Death in the U. S,” Diabetes Care, 24(3), 2001, pages 447–453.
Norhammar, A., Tenerz, A., Nilsson, G., et al., “Glucose Metabolism in Patients with Acute Myocardial Infarction and no Previous Diagnosis of Diabetes Mellitus: A Prospective Study,” Lancet, 359(9324), 2002, pages 2140–2144.
de Vegt, F., Dekker, J. M., Jager, A., et al., “Relation of Impaired Fasting and Postload Glucose with Incident Type 2 Diabetes in a Dutch Population: The Hoorn Study,” Journal of the American Medical Association, 285(16), 2001, pages 2109–2113.
Reaven, G., “Syndrome X,” Current Treatment Options in Cardiovascular Medicine, 3 (4), 2001, pages 323–332.
Saydah, S. H., Fradkin, J., Cowie, C. C., “Poor Control of Risk Factors for Vascular Disease among Adults with Previously Diagnosed Diabetes,” Journal of the American Medical Association, 291(3), 2004, pages 335–342.
Chobanian, A. V., Bakris, G. L., Black, H. R., et al., “The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,” Journal of the American Medical Association, 289(19), 2003, pages 2560–2572.
Chobanian, A. V., Bakris, G. L., Black, H. R., et al., “The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report,” Journal of the American Medical Association, 289(19), 2003, pages 2560–2572.
“Research Notebook, New Guidelines Set Lower Mark for High Blood Pressure,” FDA Consumer Magazine, 37(4), available at http://www.fda.gov/fdac/403_toc.html, accessed on April 24, 2004.
Nesbitt, S. D., Julius, S., “Prehypertension: A Possible Target for Antihypertensive Medication,” Current Hypertension Reports, 2(4), 2000, pages 356–361.
US Department of Health and Human Services, “JNC 7 Express: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,” May 2003, NIH Publication No. 03–4233, available at: http://www.nhbli.nih.gov/guidelines/hypertension/jncintro.htm, accessed on February 27, 2004.
US Department of Health and Human Services, “JNC 7 Express: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,” May 2003, NIH Publication No. 03–4233, available at: http://www.nhbli.nih.gov/guidelines/hypertension/jncintro.htm, accessed on February 27, 2004.
Sowers, J. R., Epstein, M., Frohlich, E. D., “Diabetes, Hypertension, and Cardiovascular Disease: An Update,” Hypertension, 37(4), 2001, pages 1053–1059.
US Department of Health and Human Services, “JNC 7 Express: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,” May 2003, NIH Publication No. 03–4233, available at: http://www.nhbli.nih.gov/guidelines/hypertension/jncintro.htm, accessed on February 27, 2004.
Gress, T. W., Nieto, F. J., Shahar, E., et al., “Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus. Atherosclerosis Risk in Communities Study,” New England Journal of Medicine, 342( 13), 2000, pages 905–912.
Henry, P., Thomas, F., Benetos, A., et al., “Impaired Fasting Glucose, Blood Pressure and Cardiovascular Disease Mortality,” Hypertension, 40(4), 2002, pages 458–463.
American Diabetes Association, “Treatment of Hypertension in Adults with Diabetes,” Diabetes Care, 25(1), 2002, pages 199–201.
Arauz-Pacheco, C., Parrott, M. A., Raskin, P., “Hypertension Management in Adults with Diabetes,” Diabetes Care, 27(1S), 2004, pages S65-S67.
Vaskonen, T., “Dietary Minerals and Modification of Cardiovascular Risk Factors,” Journal of Nutritional Biochemistry, 14(9), 2003, pages 492–506.
Quinones-Galvan, A., Ferrannini, E., “Renal Effects of Insulin in Man,” Journal of Nephrology, 10(4), 1997, pages 188–191.
Phinney, S. D., Bistrian, B. R., Evans, W. J., et al., “The Human Metabolic Response to Chronic Ketosis without Caloric Restriction: Preservation of Submaximal Exercise Capability with Reduced Carbohydrate Oxidation,” Metabolism: Clinical and Experimental, 32(8), 1983, pages 769–776.
Whelton, S. P., Chin, A., Xin, X., et al., “Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials,” Annals of Internal Medicine, 136(7), 2002, pages 493–503.
Bjorntorp, P., “Do Stress Reactions Cause Abdominal Obesity and Comorbidities?” Obesity Reviews, 2(2), 2001, pages 73–86.
Brunner, E. J., Hemingway, H., Walker, B. R., et al., “Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome: Nested Case-Control Study,” Circulation, 106(21), 2002, pages 2659–2665.
Bjorntorp, P., “Do Stress Reactions Cause Abdominal Obesity and Comorbidities?” Obesity Reviews, 2(2), 2001, pages 73–86.
Brunner, E. J., Hemingway, H., Walker, B. R., et al., “Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome: Nested Case-Control Study,” Circulation, 106(21), 2002, pages 2659–2665.
Leproult, R., Van Reeth, O., Byrne, M. M., et al., “Sleepiness, Performance, and Neuroendocrine Function During Sleep Deprivation: Effects of Exposure to Bright Light or Exercise,” Journal of Biological Rhythms, 12(3), 1997, pages 245–258.
Vgontzas, A. N., Tsigos, C., Bixler, E. O., et al., “Chronic Insomnia and Activity of the Stress System: A Preliminary Study,” Journal of Psychosomatic Research, 45(1S), 1998, pages 21–31.
Arauz-Pacheco, C., Parrott, M. A., Raskin, P., “Hypertension Management in Adults with Diabetes,” Diabetes Care, 27(1S), 2004, pages S65-S67.
Gress, T. W., Nieto, F. J., Shahar, E., et al., “Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus. Atherosclerosis Risk in Communities Study,” New England Journal of Medicine, 342(13), 2000, pages 905–912.
Pollare, T., Lithell, H., Berne, C., “A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with Hypertension,” New England Journal of Medicine, 321(13), 1989, pages 868–873.
Alderman, M. H., Cohen, H., Madhavan, S., “Diabetes and Cardiovascular Events in Hypertensive Patients,” Hypertension, 33(5), 1999, pages 1130–1134.
Dunder, K., Lind, L., Zethelius, B., et al., “Increase in Blood Glucose Concentration During Antihypertensive Treatment as a Predictor of Myocardial Infarction: Population Based Cohort Study,” British Medical Journal, 326(7391), 2003, page 681–686.
Quinones-Galvan, A., Ferrannini, E., “Renal Effects of Insulin in Man,” Journal of Nephrology, 10(4), 1997, pages 188–191.
Mora-Rodriguez, R., Hodgkinson, B. J., Byerley, L. O., et al., “Effects of Beta-Adrenergic Receptor Stimulation and Blockade on Substrate Metabolism During Submaximal Exercise,” American Journal of Physiology. Endocrinology and Metabolism, 280(5), 2001, pages E752–760.
Imazu, M., “Hypertension and Insulin Disorders,” Current Hypertension Reports, 4(6), 2002, pages 477–482.
Mills, G. A., Horn, J. R., “Beta-Blockers and Glucose Control,” Drug Intelligence and Clinical Pharmacy, 19(4), 1985, pages 246–251.
Marcus, A. O., “Safety of Drugs Commonly Used to Treat Hypertension, Dyslipidemia, and Type 2 Diabetes (the Metabolic Syndrome): Part 1,” Diabetes Technology & Therapeutics, 2(1), 2000, pages 101–110.
Devoy, M. A., Tomson, C. R., Edmunds, M. E., et al., “Deterioration in Renal Function Associated with Angiotensin Converting Enzyme Inhibitor Therapy Is Not Always Reversible,” Journal of Internal Medicine, 232(6), 1992, pages 493–498.
Wargo, K. A., Chong, K., Chan, E. C., “Acute Renal Failure Secondary to Angiotensin II Receptor Blockade in a Patient with Bilateral Renal Artery Stenosis,” Pharmacotherapy, 23 (9), 2003, pages 1199–1204.
Garnt, P. J., Davies, J. A., “Cardiovascular Diseases and Diabetes,” In: Textbook of Diabetes, Pickup, J. C. & Williams, G. (Eds.), Blackwell Publishing, 3rd Edition, 2002. Malden, MA.
American Heart Association. Heart Disease and Stroke Statistics-2004 Update. Dallas, Tex.: American Heart Association, 2003.
Haffner, S. M., Lehto, S., Ronnemaa, T., et al., “Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction,” New England Journal of Medicine, 339(4), 1998, pages 229–234.
Hu, F. B., Stampfer, M. J., Solomon, C. G., et al., “The Impact of Diabetes Mellitus on Mortality from All Causes and Coronary Heart Disease in Women: 20 Years of Follow-Up,” Archives of Internal Medicine, 161(14), 2001, pages 1717–1723.
Balkau, B., Shipley, M., Jarrett, R. J., et al., “High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men. 20-Year Follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study,” Diabetes Care, 21(3), 1998, pages 360–367.
Kenchaiah, S., Evans, J. C., Levy, D., et al., “Obesity and the Risk of Heart Failure,” New England Journal of Medicine, 347(5), 2002, pages 305–313.
Kirpichnikov, D., McFarlane, S. I., Sowers, J. R., “Heart Failure in Diabetic Patients: Utility of Beta-Blockade,” Journal of Cardiac Failure, 9(4), 2003, pages 333–344.
Gaziano, J. M., Hennekens, C. H., O’Donnell, C. J., et al., “Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction,” Circulation, 96(8), 1997, pages 2520–2525.
Abbasi, F., McLaughlin, T., Lamendola, C., et al., “High Carbohydrate Diets, Triglyceride-Rich Lipoproteins, and Coronary Heart Disease Risk,” American Journal of Cardiology, 85(1), 2000, pages 45–48.
Assmann, G., Schulte, H., Funke, H., et al., “The Emergence of Triglycerides as a Significant Independent Risk Factor in Coronary Artery Disease,” European Heart Journal, 19 Suppl M, 1998, pages M8-M 14.
St-Pierre, A. C., Ruel, I. L., Cantin, B., et al., “Comparison of Various Electrophoretic Characteristics of LDL Particles and Their Relationship to the Risk of Ischemic Heart Disease,” Circulation, 104(19), 2001, pages 2295–2299.
Garvey, W. T., Kwon, S., Zheng, D., et al., “Effects of Insulin Resistance and Type 2 Diabetes on Lipoprotein Subclass Particle Size and Concentration Determined by Nuclear Magnetic Resonance,” Diabetes, 52(2), 2003, pages 453–462.
Hickey, J. T., Hickey, L., Yancy, W. S. J., et al., “Clinical Use of a Carbohydrate-Restricted Diet to Treat the Dyslipidemia of the Metabolic Syndrome,” Metabolic Syndrome and Related Disorders, 1(3), 2003, pages 227–232.
Westman, E. C., Yancy, W. S., Jr., Guyton, J. S., “Effect of a Low Carbohydrate Ketogenic Diet Program on Fasting Lipid Subfractions,” Circulation, 106(19(SII)), 2002, page 727.
Luc, G., Bard, J. M., Arveiler, D., et al., “Lipoprotein (a) as a Predictor of Coronary Heart Disease: The Prime Study,” Atherosclerosis, 163(2), 2002, pages 377–384.
Gotto, A. M., Jr., Brinton, E. A., “Assessing Low Levels of High-Density Lipoprotein Cholesterol as a Risk Factor in Coronary Heart Disease: A Working Group Report and Update,” Journal of the American College of Cardiology, 43(5), 2004, pages 717–724.
Hickey, J. T., Hickey, L., Yancy, W. S. J., et al., “Clinical Use of a Carbohydrate-Restricted Diet to Treat the Dyslipidemia of the Metabolic Syndrome,” Metabolic Syndrome and Related Disorders, 1(3), 2003, pages 227–232.
Westman, E. C., Mavropoulos, J., Yancy, W. S., et al., “A Review of Low-Carbohydrate Ketogenic Diets,” Current Atherosclerosis Reports, 5(6), 2003, pages 476–483.
Hudgins, L. C., “Effect of High-Carbohydrate Feeding on Triglyceride and Saturated Fatty Acid Synthesis,” Proceedings of the Society for Experimental Biology and Medicine, 225(3), 2000, pages 178–183.
Hudgins, L. C., Hellerstein, M. K., Seidman, C. E., et al., “Relationship between Carbohydrate-Induced Hypertriglyceridemia and Fatty Acid Synthesis in Lean and Obese Subjects,” Journal of Lipid Research, 41(4), 2000, pages 595–604.
Gaziano, J. M., Hennekens, C. H., O’Donnell, C. J., et al., “Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction,” Circulation, 96(8), 1997, pages 2520–2525.
Austin, M. A., Hokanson, J. E., Edwards, K. L., “Hypertriglyceridemia as a Cardiovascular Risk Factor,” American Journal of Cardiology, 81(4A), 1998, pages 7B-12B.
Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults, “Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),” Journal of the American Medical Association, 285(19), 2001, pages 2486–2497.
Ashton, E., Liew, D., Krum, H., “Should Patients with Chronic Heart Failure Be Treated with ‘Statins’?” Heart Failure Monitor, 3(3), 2003, pages 82–86.
Ashton, E., Liew, D., Krum, H., “Should Patients with Chronic Heart Failure Be Treated with ‘Statins’?” Heart Failure Monitor, 3(3), 2003, pages 82–86.
Westman, E. C., Mavropoulos, J., Yancy, W. S., et al., “A Review of Low-Carbohydrate Ketogenic Diets,” Current Atherosclerosis Reports, 5(6), 2003, pages 476–483.
Arcaro, G., Cretti, A., Balzano, S., et al., “Insulin Causes Endothelial Dysfunction in Humans: Sites and Mechanisms,” Circulation, 105(5), 2002, pages 576–582.
Festa, A., Hanley, A. J., Tracy, R. P., et al., “Inflammation in the Prediabetic State Is Related to Increased Insulin Resistance Rather Than Decreased Insulin Secretion,” Circulation, 108(15), 2003, pages 1822–1830.
Caballero, A. E., “Endothelial Dysfunction in Obesity and Insulin Resistance: A Road to Diabetes and Heart Disease,” Obesity Research, 11(11), 2003, pages 1278–1289.
Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults, “Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),” Journal of the American Medical Association, 285(19), 2001, pages 2486–2497.
Fedder, D. O., Koro, C. E., L’Italien, G. J., “New National Cholesterol Education Program III Guidelines for Primary Prevention Lipid-Lowering Drug Therapy: Projected Impact on the Size, Sex, and Age Distribution of the Treatment-Eligible Population,” Circulation, 105(2), 2002, pages 152–156.
Reaven, G., “Syndrome X,” Current Treatment Options in Cardiovascular Medicine, 3 (4), 2001, pages 323–332.
Sharman, M. J., Kraemer, W. J., Love, D. M., et al., “A Ketogenic Diet Favorably Affects Serum Biomarkers for Cardiovascular Disease in Normal-Weight Men,” Journal of Nutrition, 132(7), 2002, pages 1879–1885.
Volek, J. S., Sharman, M. J., Gomez, A. L., et al., “An Isoenergetic Very Low Carbohydrate Diet Improves Serum HDL Cholesterol and Triacylglycerol Concentrations, the Total Cholesterol to HDL Cholesterol Ratio and Postprandial Pipemic Responses Compared with a Low Fat Diet in Normal Weight, Normolipidemic Women,” Journal of Nutrition, 133(9), 2003, pages 2756–2761.
Hudgins, L. C., “Effect of High-Carbohydrate Feeding on Triglyceride and Saturated Fatty Acid Synthesis,” Proceedings of the Society for Experimental Biology and Medicine, 225(3), 2000, pages 178–183.
Caballero, A. E., “Endothelial Dysfunction in Obesity and Insulin Resistance: A Road to Diabetes and Heart Disease,” Obesity Research, 11 (11), 2003, pages 1278–1289.
Hoogeveen, E. K., Kostense, P. J., Jakobs, C., et al., “Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes: 5-Year Follow-up of the Hoorn Study,” Circulation, 101(13), 2000, pages 1506–1511.
Soinio, M., Marniemi, J., Laakso, M., et al., “Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type 2 Diabetes Mellitus,” Annals of Internal Medicine, 140(2), 2004, pages 94–100.
Buysschaert, M., Dramais, A. S., Wallemacq, P. E., et al., “Hyperhomocysteinemia in Type 2 Diabetes: Relationship to Macroangiopathy, Nephropathy, and Insulin Resistance,” Diabetes Care, 23(12), 2000, pages 1816–1822.
Ridker, P. M., Cushman, M., Stampfer, M. J., et al., “Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men,” New England Journal of Medicine, 336(14), 1997, pages 973–979.
Ridker, P. M., Hennekens, C. H., Buring, J. E., et al., “C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women,” New England Journal of Medicine, 342(12), 2000, pages 836–843.
Forouhi, N. G., Sattar, N., McKeigue, P. M., “Relation of C-Reactive Protein to Body Fat Distribution and Features of the Metabolic Syndrome in Europeans and South Asians,” International Journal of Obesity and Related Metabolic Disorders, 25(9), 2001, pages 1327–1331.
Ziccardi, P., Nappo, F., Giugliano, G., et al., “Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women after Weight Loss Over One Year,” Circulation, 105(7), 2002, pages 804–809.
Volek, J. S., Sharman, M. J., Gomez, A. L., et al., “An Isoenergetic Very Low Carbohydrate Diet Improves Serum HDL Cholesterol and Triacylglycerol Concentrations, the Total Cholesterol to HDL Cholesterol Ratio and Postprandial Pipemic Responses Compared with a Low Fat Diet in Normal Weight, Normolipidemic Women,” Journal of Nutrition, 133(9), 2003, pages 2756–2761.
Ford, E. S., “The Metabolic Syndrome and C-Reactive Protein, Fibrinogen, and Leukocyte Count: Findings from the Third National Health and Nutrition Examination Survey,” Atherosclerosis, 168(2), 2003, pages 351–358.
Atkins, R. C., Dr. Atkins’ New Diet Revolution, Avon Books, 2002.
Atkins, R. C., Atkins for Life, 1 st edition, St. Martin’s Press, 2003.
Atkins Health & Medical Information Services, The Atkins Essentials: A Two-Week Program to Jump-start Your Low Carb Lifestyle, Avon Books, 2003.
Atkins, R. C., Dr. Atkins’ New Carbohydrate Gram Counter, M. Evans & Company Inc., 2002.
Gandhi, T. K., Weingart, S. N., Borus, J., et al., “Adverse Drug Events in Ambulatory Care,” New England Journal of Medicine, 348(16), 2003, pages 1556–1564.
Lazarou, J., Pomeranz, B. H., Corey, P. N., “Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-Analysis of Prospective Studies,” Journal of the American Medical Association, 279(15), 1998, pages 1200–1205.
Whelton, P. K., Appel, L. J., Espeland, M. A., et al., “Sodium Reduction and Weight Loss in the Treatment of Hypertension in Older Persons: A Randomized Controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE). TONE Collaborative Research Group,” Journal of the American Medical Association, 279(11), 1998, pages 839–846.
Simopoulos, A. P., “The Importance of the Ratio of Omega-6/ Omega-3 Essential Fatty Acids,” Biomedicine and Pharmacotherapy, 56(8), 2002, pages 365–379.
Sharman, M. J., Kraemer, W. J., Love, D. M., et al., “A Ketogenic Diet Favorably Affects Serum Biomarkers for Cardiovascular Disease in Normal-Weight Men,” Journal of Nutrition, 132(7), 2002, pages 1879–1885.
Hays, J. H., Gorman, R. T., Shakir, K. M., “Results of Use of Metformin and Replacement of Starch with Saturated Fat in Diets of Patients with Type 2 Diabetes,” Endocrine Practice, 8(3), 2002, pages 177–183.
Hu, F. B., Stampfer, M. J., Manson, J. E., et al., “Dietary Saturated Fats and Their Food Sources in Relation to the Risk of Coronary Heart Disease in Women,” American Journal of Clinical Nutrition, 70(6), 1999, pages 1001–1008.
He, K., Merchant, A., Rimm, E. B., et al., “Dietary Fat Intake and Risk of Stroke in Male US Healthcare Professionals: 14 Year Prospective Cohort Study,” British Medical Journal, 327(7418), 2003, pages 777–782.
Salmeron, J., Manson, J. E., Stampfer, M. J., et al., “Dietary Fiber, Glycemic Load, and Risk of Non-Insulin-Dependent Diabetes Mellitus in Women,” Journal of the American Medical Association, 277(6), 1997, pages 472–477.
Mensink, R. P., Katan, M. B., “Effect of Monounsaturated Fatty Acids Versus Complex Carbohydrates on High-Density Lipoproteins in Healthy Men and Women,” Lancet, 1(8525), 1987, pages 122–125.
Lee, K. W., Lip, G. Y., “The Role of Omega-3 Fatty Acids in the Secondary Prevention of Cardiovascular Disease,” The Quarterly Journal of Medicine, 96(7), 2003, pages 465–480.
Kris-Etherton, P. M., Harris, W. S., Appel, L. J., “Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, 23(2), 2003, pages e20–30.
Kris-Etherton, P. M., Harris, W. S., Appel, L. J., “Omega-3 Fatty Acids and Cardiovascular Disease: New Recommendations from the American Heart Association,” Arteriosclerosis, Thrombosis, and Vascular Biology, 23(2), 2003, pages 151–152.
Erkkila, A. T., Lehto, S., Pyorala, K., et al., “N-3 Fatty Acids and 5-Y Risks of Death and Cardiovascular Disease Events in Patients with Coronary Artery Disease,” American Journal of Clinical Nutrition, 78(1), 2003, pages 65–71.
Friedberg, C. E., Janssen, M. J., Heine, R. J., et al., “Fish Oil and Glycemic Control in Diabetes. A Meta-Analysis,” Diabetes Care, 21 (4), 1998, pages 494–500.
Lee, K. W., Lip, G. Y., “The Role of Omega-3 Fatty Acids in the Secondary Prevention of Cardiovascular Disease,” The Quarterly Journal of Medicine, 96(7), 2003, pages 465–480.
Toft, I., Bonaa, K. H., Ingebretsen, O. C., et al., “Effects of N-3 Polyunsaturated Fatty Acids on Glucose Homeostasis and Blood Pressure in Essential Hypertension. A Randomized, Controlled Trial,” Annals of Internal Medicine, 123 (12), 1995, pages 911–918.
Foran, S. E., Flood, J. G., Lewandrowski, K. B., “Measurement of Mercury Levels in Concentrated Over-the-Counter Fish Oil Preparations: Is Fish Oil Healthier Than Fish?” Archives of Pathology and Laboratory Medicine, 127(12), 2003, pages 1603–1605.
Wen, Z. Y., Chen, F., “Heterotrophic Production of Eicosapentaenoic Acid by Microalgae,” Biotechnology Advances, 21 (4), 2003, pages 273–294.
Crawford, M., Galli, C., Visioli, F., et al., “Role of Plant-Derived Omega-3 Fatty Acids in Human Nutrition,” Annals of Nutrition and Metabolism, 44(5–6), 2000, pages 263–265.
Ascherio, A., “Epidemiologic Studies on Dietary Fats and Coronary Heart Disease,” American Journal of Medicine, 113(S9B), 2002, pages 9S-12S.
Sacks, F. M., Katan, M., “Randomized Clinical Trials on the Effects of Dietary Fat and Carbohydrate on Plasma Lipoproteins and Cardiovascular Disease,” American Journal of Medicine, 113(S9B), 2002, pages 13S-24S.
Willett, W. C., Ascherio, A., “Trans Fatty Acids: Are the Effects Only Marginal?” American Journal of Public Health, 84(5), 1994, pages 722–724.
Schnohr, P., Thomsen, O. O., Riis Hansen, P., et al., “Egg Consumption and High-Density-Lipoprotein Cholesterol,” Journal of Internal Medicine, 235(3), 1994, pages 249–251.
Knopp, R. H., Retzlaff, B., Fish, B., et al., “Effects of Insulin Resistance and Obesity on Lipoproteins and Sensitivity to Egg Feeding,” Arteriosclerosis, Thrombosis, and Vascular Biology, 23(8), 2003, pages 1437–1443.
Reaven, G. M., Abbasi, F., Bernhart, S., et al., “Insulin Resistance, Dietary Cholesterol, and Cholesterol Concentration in Postmenopausal Women,” Metabolism: Clinical and Experimental, 50(5), 2001, pages 594–597.
Layman, D. K., “The Role of Leucine in Weight Loss Diets and Glucose Homeostasis,” Journal of Nutrition, 133(1S), 2003, pages 261S-267S.
Gannon, M. C., Nuttall, F. Q., Saeed, A., et al., “An Increase in Dietary Protein Improves the Blood Glucose Response in Persons with Type 2 Diabetes,” American Journal of Clinical Nutrition, 78(4), 2003, pages 734–741.
Layman, D. K., Shiue, H., Sather, C., et al., “Increased Dietary Protein Modifies Glucose and Insulin Homeostasis in Adult Women During Weight Loss,” Journal of Nutrition, 133(2), 2003, pages 405–410.
Layman, D. K., Baum, J. I., “Dietary Protein Impact on Glycemic Control During Weight Loss,” Journal of Nutrition, 134(4), 2004, pages 968S-973S.
Hu, F. B., Stampfer, M. J., Manson, J. E., et al., “Dietary Protein and Risk of Ischemic Heart Disease in Women,” American Journal of Clinical Nutrition, 70(2), 1999, pages 221–227.
Stamler, J., Elliott, P., Kesteloot, H., et al., “Inverse Relation of Dietary Protein Markers with Blood Pressure. Findings for 10,020 Men and Women in the INTERSALT Study. INTERSALT Cooperative Research Group. International Study of Salt and Blood Pressure,” Circulation, 94(7), 1996, pages 1629–1634.
Facchini, F. S., Saylor, K. L., “A Low-Iron-Available, Polyphenol-Enriched, Carbohydrate-Restricted Diet to Slow Progression of Diabetic Nephropathy,” Diabetes, 52(5), 2003, pages 1204–1209.
Jameel, N., Pugh, J. A., Mitchell, B. D., et al., “Dietary Protein Intake Is Not Correlated with Clinical Proteinuria in NIDDM,” Diabetes Care, 15(2), 1992, pages 178–183.
Meloni, C., Morosetti, M., Suraci, C., et al., “Severe Dietary Protein Restriction in Overt Diabetic Nephropathy: Benefits or Risks?” Journal of Renal Nutrition, 12(2), 2002, pages 96–101.
Hegsted, M., Schuette, S. A., Zemel, M. B., et al., “Urinary Calcium and Calcium Balance in Young Men as Affected by Level of Protein and Phosphorus Intake,” Journal of Nutrition, 111 (3), 1981, pages 553–562.
Spencer, H., Kramer, L., DeBartolo, M., et al., “Further Studies of the Effect of a High Protein Diet as Meat on Calcium Metabolism,” American Journal of Clinical Nutrition, 37(6), 1983, pages 924–929.
Kerstetter, J. E., O’Brien, K. O., Insogna, K. L., “Dietary Protein Affects Intestinal Calcium Absorption,” American Journal of Clinical Nutrition, 68(4), 1998, pages 859–865.
Hannan, M. T., Tucker, K. L., Dawson-Hughes, B., et al., “Effect of Dietary Protein on Bone Loss in Elderly Men and Women: The Framingham Osteoporosis Study,” Journal of Bone and Mineral Research, 15(12), 2000, pages 2504–2512.
Dawson-Hughes, B., Harris, S. S., “Calcium Intake Influences the Association of Protein Intake with Rates of Bone Loss in Elderly Men and Women,” American Journal of Clinical Nutrition, 75(4), 2002, pages 773–779.
Dawson-Hughes, B., Harris, S. S., Rasmussen, H., et al., “Effect of Dietary Protein Supplements on Calcium Excretion in Healthy Older Men and Women,” Journal of Clinical Endocrinology and Metabolism, 89(3), 2004, pages 1169–1173.
Kurzer, M. S., “Phytoestrogen Supplement Use by Women,” Journal of Nutrition, 133(6), 2003, pages 1983S-1986S.
Jenkins, D. J., Wolever, T. M., Taylor, R. H., et al., “Glycemic Index of Foods: A Physiological Basis for Carbohydrate Exchange,” American Journal of Clinical Nutrition, 34(3), 1981, pages 362–366.
Salmeron, J., Manson, J. E., Stampfer, M. J., et al., “Dietary Fiber, Glycemic Load, and Risk of Non-Insulin-Dependent Diabetes Mellitus in Women,” Journal of the American Medical Association, 277(6), 1997, pages 472–477.
Ludwig, D. S., “Glycemic Load Comes of Age,” Journal of Nutrition, 133(9), 2003, pages 2695–2696.
Liu, S., Willett, W. C., Stampfer, M. J., et al., “A Prospective Study of Dietary Glycemic Load, Carbohydrate Intake, and Risk of Coronary Heart Disease in US Women,” American Journal of Clinical Nutrition, 71(6), 2000, pages 1455–1461.
Ford, E. S., Liu, S., “Glycemic Index and Serum High-Density Lipoprotein Cholesterol Concentration among US Adults,” Archives of Internal Medicine, 161 (4), 2001, pages 572–576.
Liu, S., Manson, J. E., Stampfer, M. J., et al., “Dietary Glycemic Load Assessed by Food-Frequency Questionnaire in Relation to Plasma High-Density-Lipoprotein Cholesterol and Fasting Plasma Triacylglycerols in Postmenopausal Women,” American Journal of Clinical Nutrition, 73(3), 2001, pages 560–566.
Ludwig, D. S., Majzoub, J. A., Al-Zahrani, A., et al., “High Glycemic Index Foods, Overeating, and Obesity,” Pediatrics, 103(3), 1999, page E26:1–6.
Jarvi, A. E., Karlstrom, B. E., Granfeldt, Y. E., et al., “Improved Glycemic Control and Lipid Profile and Normalized Fibrinolytic Activity on a Low-Glycemic Index Diet in Type 2 Diabetic Patients,” Diabetes Care, 22(1), 1999, pages 10–18.
Atkins, R. C., Dr. Atkins’ New Carbohydrate Gram Counter, M. Evans & Company Inc., 2002.
Institute of Medicine of the National Academies, “Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids,” available at: http://books. nap.edu/books/0309085373/html/index.html, accessed on April 9, 2004.
Bialostosky, K., et al, “Dietary Intake of Macronutrients, Micronutrients, and Other Constituents: United States, 1988–94,” Vital Health Statistics, 11 (245), 2002.
Bazzano, L. A., He, J., Ogden, L. G., et al., “Fruit and Vegetable Intake and Risk of Cardiovascular Disease in US Adults: The First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study,” American Journal of Clinical Nutrition, 76 ( 1 ), 2002, pages 93–99.
Bazzano, L. A., He, J., Ogden, L. G., et al., “Fruit and Vegetable Intake and Risk of Cardiovascular Disease in US Adults: The First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study,” American Journal of Clinical Nutrition, 76 ( 1 ), 2002, pages 93–99.
Williams, D. E., Wareham, N. J., Cox, B. D., et al., “Frequent Salad Vegetable Consumption Is Associated with a Reduction in the Risk of Diabetes Mellitus,” Journal of Clinical Epidemiology, 52(4), 1999, pages 329–335.
Johnston, C. S., Taylor, C. A., Hampl, J. S., “More Americans Are Eating ‘5 a Day’ but Intakes of Dark Green and Cruciferous Vegetables Remain Low,” Journal of Nutrition, 130(12), 2000, pages 3063–3067.
Foster-Powell, K., Holt, S. H., Brand-Miller, J. C., “International Table of Glycemic Index and Glycemic Load Values: 2002,” American Journal of Clinical Nutrition, 76( 1 ), 2002, pages 5–56.
Sullivan, M. J., Scott, R. L., “Postprandial Glycemic Response to Orange Juice and Nondiet Cola: Is There a Difference?” Diabetes Educator, 17(4), 1991, pages 274–278.
Bolton, R. P., Heaton, K. W., Burroughs, L. F., “The Role of Dietary Fiber in Satiety, Glucose, and Insulin: Studies with Fruit and Fruit Juice,” American Journal of Clinical Nutrition, 34(2), 1981, pages 211–217.
Gannon, M. C., Nuttall, F. Q., Krezowski, P. A., et al., “The Serum Insulin and Plasma Glucose Responses to Milk and Fruit Products in Type 2 (Non-Insulin-Dependent) Diabetic Patients,” Diabetologia, 29(11), 1986, pages 784–791.
Hayden, M. R., Tyagi, S. C., “Islet Redox Stress: The Manifold Toxicities of Insulin Resistance, Metabolic Syndrome and Amylin Derived Islet Amyloid in Type 2 Diabetes Mellitus,” Journal of the Pancreas, 3(4), 2002, pages 86–108.
Hayden, M. R., Tyagi, S. C., “Islet Redox Stress: The Manifold Toxicities of Insulin Resistance, Metabolic Syndrome and Amylin Derived Islet Amyloid in Type 2 Diabetes Mellitus,” Journal of the Pancreas, 3(4), 2002, pages 86–108.
Nelson, J. L., Bernstein, P. S., Schmidt, M. C., et al., “Dietary Modification and Moderate Antioxidant Supplementation Differentially Affect Serum Carotenoids, Antioxidant Levels and Markers of Oxidative Stress in Older Humans,” Journal of Nutrition, 133(10), 2003, pages 3117–3123.
Ford, E. S., Mokdad, A. H., Giles, W. H., et al., “The Metabolic Syndrome and Antioxidant Concentrations: Findings from the Third National Health and Nutrition Examination Survey,” Diabetes, 52(9), 2003, pages 2346–2352.
Fung, T. T., Manson, J. E., Solomon, C. G., et al., “The Association Between Magnesium Intake and Fasting Insulin Concentration in Healthy Middle-Aged Women,” Journal of the American College of Nutrition, 22(6), 2003, pages 533–538.
Seddon, J. M., Ajani, U. A., Sperduto, R. D., et al., “Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration. Eye Disease Case-Control Study Group,” Journal of the American Medical Association, 272(18), 1994, pages 1413–1420.
Wursch, P., Pi-Sunyer, F. X., “The Role of Viscous Soluble Fiber in the Metabolic Control of Diabetes. A Review with Special Emphasis on Cereals Rich in Beta-Glucan,” Diabetes Care, 20(11), 1997, pages 1774–1780.
Foster-Powell, K., Holt, S. H., Brand-Miller, J. C., “International Table of Glycemic Index and Glycemic Load Values: 2002,” American Journal of Clinical Nutrition, 76( 1 ), 2002, pages 5–56.
Chiasson, J. L., Josse, R. G., Gomis, R., et al., “Acarbose for Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Randomised Trial,” Lancet, 359(9323), 2002, pages 2072–2077.
Kaiser, T., Sawicki, P. T., “Acarbose for Prevention of Diabetes, Hypertension and Cardiovascular Events? A Critical Analysis of the STOP-NIDDM Data,” Diabetologia, 47(3), 2004, pages 575–580.
USDA, “Major Trends in U. S. Food Supply, 1909–99,” FoodReview, 23 ( 1 ), 2000, pages 8–15.
Sullivan, M. J., Scott, R. L., “Postprandial Glycemic Response to Orange Juice and Nondiet Cola: Is There a Difference?” Diabetes Educator, 17(4), 1991, pages 274–278.
Natah, S. S., Hussien, K. R., Tuominen, J. A., et al., “Metabolic Response to Lactitol and Xylitol in Healthy Men,” American Journal of Clinical Nutrition, 65(4), 1997, pages 947–950.
USDA, “Major Trends in U. S. Food Supply, 1909–99,” FoodReview, 23 ( 1 ), 2000, pages 8–15.
Elliott, S. S., Keim, N. L., Stern, J. S., et al., “Fructose, Weight Gain, and the Insulin Resistance Syndrome,” American Journal of Clinical Nutrition, 76(5), 2002, pages 911–922.
Foster-Powell, K., Holt, S. H., Brand-Miller, J. C., “International Table of Glycemic Index and Glycemic Load Values: 2002,” American Journal of Clinical Nutrition, 76( 1 ), 2002, pages 5–56.
Bolton, R. P., Heaton, K. W., Burroughs, L. F., “The Role of Dietary Fiber in Satiety, Glucose, and Insulin: Studies with Fruit and Fruit Juice,” American Journal of Clinical Nutrition, 34(2), 1981, pages 211–217.
Gannon, M. C., Nuttall, F. Q., Krezowski, P. A., et al., “The Serum Insulin and Plasma Glucose Responses to Milk and Fruit Products in Type 2 (Non-Insulin-Dependent) Diabetic Patients,” Diabetologia, 29(11), 1986, pages 784–791.
Sullivan, M. J., Scott, R. L., “Postprandial Glycemic Response to Orange Juice and Nondiet Cola: Is There a Difference?” Diabetes Educator, 17(4), 1991, pages 274–278.
Zemel, M. B., “Role of Dietary Calcium and Dairy Products in Modulating Adiposity,” Lipids, 38(2), 2003, pages 139–146.
Kerr, D., Sherwin, R. S., Pavalkis, F., et al., “Effect of Caffeine on the Recognition of and Responses to Hypoglycemia in Humans,” Annals of Internal Medicine, 119(8), 1993, pages 799–804.
Keijzers, G. B., De Galan, B. E., Tack, C. J., et al., “Caffeine Can Decrease Insulin Sensitivity in Humans,” Diabetes Care, 25(2), 2002, pages 364–369.
Thong, F. S., Derave, W., Kiens, B., et al., “Caffeine-Induced Impairment of Insulin Action but Not Insulin Signaling in Human Skeletal Muscle Is Reduced by Exercise,” Diabetes, 51(3), 2002, pages 583–590.
Sesso, H. D., Gaziano, J. M., Buring, J. E., et al., “Coffee and Tea Intake and the Risk of Myocardial Infarction,” American Journal of Epidemiology, 149(2), 1999, pages 162–167.
Hegarty, V. M., May, H. M., Khaw, K. T., “Tea Drinking and Bone Mineral Density in Older Women,” American Journal of Clinical Nutrition, 71 (4), 2000, pages 1003–1007.
Dulloo, A. G., Duret, C., Rohrer, D., et al., “Efficacy of a Green Tea Extract Rich in Catechin Polyphenols and Caffeine in Increasing 24-H Energy Expenditure and Fat Oxidation in Humans,” American Journal of Clinical Nutrition, 70(6), 1999, pages 1040–1045.
Hosoda, K., Wang, M. F., Liao, M. L., et al., “Antihyperglycemic Effect of Oolong Tea in Type 2 Diabetes,” Diabetes Care, 26(6), 2003, pages 1714–1718.
Caimi, G., Carollo, C., Lo Presti, R., “Diabetes Mellitus: Oxidative Stress and Wine,” Current Medical Research and Opinion, 19(7), 2003, pages 581–586.
Avogaro, A., Sambataro, M., Marangoni, A., et al., “Moderate Alcohol Consumption, Glucose Metabolism and Lipolysis: The Effect on Adiponectin and Tumor Necrosis Factor Alpha,” Journal of Endocrinological Investigation, 26(12), 2003, pages 1213–1218.
Lange, J., Arends, J., Willms, B., “Alcohol-Induced Hypoglycemia in Type I Diabetic Patients,” Medizinisohe Klinik (Munich), 86(11), 1991, pages 551–554.
Swade, T. F., Emanuele, N. V., “Alcohol & Diabetes,” Comprehensive Therapy, 23(2), 1997, pages 135–140.
Sacks, D. B., Bruns, D. E., Goldstein, D. E., et al., “Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus,” Clinical Chemistry, 48(3), 2002, pages 436–472.
Fletcher, R. H., Fairfield, K. M., “Vitamins for Chronic Disease Prevention in Adults: Clinical Applications,” Journal of the American Medical Association, 287(23), 2002, pages 3127–3129.
Barringer, T. A., Kirk, J. K., Santaniello, A. C., et al., “Effect of a Multivitamin and Mineral Supplement on Infection and Quality of Life. A Randomized, Double-Blind, Placebo-Controlled Trial,” Annals of Internal Medicine, 138(5), 2003, pages 365–371.
Hayden, M. R., Tyagi, S. C., “Islet Redox Stress: The Manifold Toxicities of Insulin Resistance, Metabolic Syndrome and Amylin Derived Islet Amyloid in Type 2 Diabetes Mellitus,” Journal of the Pancreas, 3(4), 2002, pages 86–108.
Jiang, R., Manson, J. E., Meigs, J. B., et al., “Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women,” Journal of the American Medical Association, 291 (6), 2004, pages 711–717.
Hayden, M. R., Tyagi, S. C., “Islet Redox Stress: The Manifold Toxicities of Insulin Resistance, Metabolic Syndrome and Amylin Derived Islet Amyloid in Type 2 Diabetes Mellitus,” Journal of the Pancreas, 3(4), 2002, pages 86–108.
Sinclair, A. J., Taylor, P. B., Lunec, J., et al., “Low Plasma Ascorbate Levels in Patients with Type 2 Diabetes Mellitus Consuming Adequate Dietary Vitamin C,” Diabetic Medicine, 11 (9), 1994, pages 893–898.
Sargeant, L. A., Wareham, N. J., Bingham, S., et al., “Vitamin C and Hyperglycemia in the European Prospective Investigation into Cancer—Norfolk (EPIC-Norfolk) Study: A Population-Based Study,” Diabetes Care, 23(6), 2000, pages 726–732.
Natali, A., Sironi, A. M., Toschi, E., et al., “Effect of Vitamin C on Forearm Blood Flow and Glucose Metabolism in Essential Hypertension,” Arteriosclerosis, Thrombosis, and Vascular Biology, 20(11), 2000, pages 2401–2406.
Ting, H. H., Timimi, F. K., Boles, K. S., et al., “Vitamin C Improves Endothelium-Dependent Vasodilation in Patients with Non-Insulin-Dependent Diabetes Mellitus,” Journal of Clinical Investigation, 97(1), 1996, pages 22–28
Carr, A., Frei, B., “The Role of Natural Antioxidants in Preserving the Biological Activity of Endothelium-Derived Nitric Oxide,” Free Radical Biology and Medicine, 28(12), 2000, pages 1806–1814.
Price, K. D., Price, K. S., Reynolds, R. D., “ Hyperglycemia-Induced Ascorbic Acid Deficiency Promotes Endothelial Dysfunction and the Development of Atherosclerosis,” Atherosclerosis, 158(1), 2001, pages 1–12.
Trumbo, P., Schlicker, S., Yates, A. A., et al., “Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids,” Journal of the American Dietetic Association, 102(11), 2002, pages 1621–1630.
Paolisso, G., D’Amore, A., Galzerano, D., et al., “Daily Vitamin E Supplements Improve Metabolic Control but Not Insulin Secretion in Elderly Type II Diabetic Patients,” Diabetes Care, 16(11), 1993, pages 1433–1437.
Devaraj, S., Jialal, I., “Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients with and without Macrovascular Complications: The Effect of Alpha-Tocopherol Supplementation,” Circulation, 102(2), 2000, pages 191–196.
Trumbo, P., Schlicker, S., Yates, A. A., et al., “Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids,” Journal of the American Dietetic Association, 102(11), 2002, pages 1621–1630.
Ametov, A. S., Barinov, A., Dyck, P. J., et al., “The Sensory Symptoms of Diabetic Polyneuropathy Are Improved with Alpha-Lipoic Acid: The Sydney Trial,” Diabetes Care, 26(3), 2003, pages 770–776.
Maebashi, M., Makino, Y., Kurukawa, Y., et al., “Therapeutic Evaluation of the Effect of Biotin on Hyperglycemia in Patients with Non-Insulin Dependent Diabetes Mellitus,” Journal of Clinical Biochemistry and Nutrition, 14, 1993, pages 211–218.
McCarty, M. F., “Toward Practical Prevention of Type 2 Diabetes,” Medical Hypotheses, 54(5), 2000, pages 786–793.
McCarty, M. F., “Toward a Wholly Nutritional Therapy for Type 2 Diabetes,” Medical Hypotheses, 54(3), 2000, pages 483–487.
Koutsikos, D., Agroyannis, B., Tzanatos-Exarchou, H., “Biotin for Diabetic Peripheral Neuropathy,” Biomedicine and Pharmacotherapy, 44(10), 1990, pages 511–514.
Maffucci, T., Brancaccio, A., Piccolo, E., et al., “Insulin Induces Phosphatidylinositol-3-Phosphate Formation through Tc10 Activation ,” EMBO Journal, 22( 16), 2003, pages 4178–4189.
Jones, A. W., Geisbuhler, B. B., Shukla, S. D., et al., “Altered Biochemical and Functional Responses in Aorta from Hypertensive Rats,” Hypertension, 11 (6 Pt 2), 1988, pages 627–634.
Anderson, R. A., “Chromium, Glucose Intolerance and Diabetes,” Journal of the American College of Nutrition, 17(6), 1998, pages 548–555.
Ducros, V., “Chromium Metabolism. A Literature Review,” Biological Trace Element Research, 32, 1992, pages 65–77.
Anderson, R. A., Cheng, N., Bryden, N. A., et al., “Elevated Intakes of Supplemental Chromium Improve Glucose and Insulin Variables in Individuals with Type 2 Diabetes,” Diabetes, 46(11), 1997, pages 1786–1791.
Anderson, R. A., “Chromium, Glucose Intolerance and Diabetes,” Journal of the American College of Nutrition, 17(6), 1998, pages 548–555.
Stearns, D. M., Silveira, S. M., Wolf, K. K., et al., “Chromium(III) Tris(Picolinate) Is Mutagenic at the Hypoxanthine (Guanine) Phosphoribosyltransferase Locus in Chinese Hamster Ovary Cells,” Mutation Research, 513 ( 1–2), 2002, pages 135–142.
Kao, W. H., Folsom, A. R., Nieto, F. J., et al., “Serum and Dietary Magnesium and the Risk for Type 2 Diabetes Mellitus: The Atherosclerosis Risk in Communities Study,” Archives of Internal Medicine, 159(18), 1999, pages 2151–2159.
Rodriguez-Moran, M., Guerrero-Romero, F., “Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic Subjects: A Randomized Double-Blind Controlled Trial,” Diabetes Care, 26(4), 2003, pages 1147–1152.
White,J. R., Campbell, R. K., “Magnesium and Diabetes: A Review,” The Annals of Pharmacotherapy, 27(6), 1993, pages 775–780.
Bauman, W. A., Shaw, S., Jayatilleke, E., et al., “Increased Intake of Calcium Reverses Vitamin B12 Malabsorption Induced by Metformin,” Diabetes Care, 23(9), 2000, pages 1227–1231.
Trumbo, P., Schlicker, S., Yates, A. A., et al., “Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids,” Journal of the American Dietetic Association, 102(11), 2002, pages 1621–1630.
Zemel, M. B., “Role of Dietary Calcium and Dairy Products in Modulating Adiposity,” Lipids, 38(2), 2003, pages 139–146.
DiSilvestro, R. A., “Zinc in Relation to Diabetes and Oxidative Disease,” Journal of Nutrition, 130(5S), 2000, pages 1509S-1511S.
Chausmer, A. B., “Zinc, Insulin and Diabetes,” Journal of the American College of Nutrition, 17(2), 1998, pages 109–115.
Fernandez-Real, J. M., Lopez-Bermejo, A., Ricart, W., “Cross-Talk between Iron Metabolism and Diabetes,” Diabetes, 51(8), 2002, pages 2348–2354.
Jiang, R., Manson, J. E., Meigs, J. B., et al., “Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women,” Journal of the American Medical Association, 291 (6), 2004, pages 711–717.
Hodgson, J. M., Watts, G. F., Playford, D. A., et al., “Coenzyme Q10 Improves Blood Pressure and Glycaemic Control: A Controlled Trial in Subjects with Type 2 Diabetes,” European Journal of Clinical Nutrition, 56(11), 2002, pages 1137–1142.
van Loon, L. J., Kruijshoop, M., Menheere, P. P., et al., “Amino Acid Ingestion Strongly Enhances Insulin Secretion in Patients with Long-Term Type 2 Diabetes,” Diabetes Care, 26(3), 2003, pages 625–630.
Layman, D. K., Shiue, H., Sather, C., et al., “Increased Dietary Protein Modifies Glucose and Insulin Homeostasis in Adult Women During Weight Loss,” Journal of Nutrition, 133(2), 2003, pages 405–410.
Muller, D. M., Seim, H., Kiess, W., et al., “Effects of Oral L-Carnitine Supplementation on in Vivo Long-Chain Fatty Acid Oxidation in Healthy Adults,” Metabolism: Clinical and Experimental, 51(11), 2002, pages 1389–1391.
Mingrone, G., Greco, A. V., Capristo, E., et al., “L-Carnitine Improves Glucose Disposal in Type 2 Diabetic Patients,” Journal of the American College of Nutrition, 18(1), 1999, pages 77–82.
Natali, A., Sironi, A. M., Toschi, E., et al., “Effect of Vitamin C on Forearm Blood Flow and Glucose Metabolism in Essential Hypertension,” Arteriosclerosis, Thrombosis, and Vascular Biology, 20(11), 2000, pages 2401–2406.
Reaven, P. D., Herold, D. A., Barnett, J., et al., “Effects of Vitamin E on Susceptibility of Low-Density Lipoprotein and Low-Density Lipoprotein Subfractions to Oxidation and on Protein Glycation in NIDDM,” Diabetes Care, 18(6), 1995, pages 807–816.
Dreon, D. M., Fernstrom, H. A., Campos, H., et al., “Change in Dietary Saturated Fat Intake Is Correlated with Change in Mass of Large Low-Density-Lipoprotein Particles in Men,” American Journal of Clinical Nutrition, 67(5), 1998, pages 828–836.
Hickey, J. T., Hickey, L., Yancy, W. S. J., et al., “Clinical Use of a Carbohydrate-Restricted Diet to Treat the Dyslipidemia of the Metabolic Syndrome,” Metabolic Syndrome and Related Disorders, 1 (3), 2003, pages 227–232.
Devaraj, S., Jialal, I., “Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients with and without Macrovascular Complications: The Effect of Alpha-Tocopherol Supplementation,” Circulation, 102(2), 2000, pages 191–196.
Hoogeveen, E. K., Kostense, P. J., Jakobs, C., et al., “Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes: 5-Year Follow-up of the Hoorn Study,” Circulation, 101 (13), 2000, pages 1506–1511.
Buysschaert, M., Dramais, A. S., Wallemacq, P. E., et al., “Hyperhomocysteinemia in Type 2 Diabetes: Relationship to Macroangiopathy, Nephropathy, and Insulin Resistance,” Diabetes Care, 23(12), 2000, pages 1816–1822.
Passaro, A., Calzoni, F., Volpato, S., et al., “Effect of Metabolic Control on Homocysteine Levels in Type 2 Diabetic Patients: A 3-Year Follow-Up,” Journal of Internal Medicine, 254(3), 2003, pages 264–271.
Desouza, C., Keebler, M., McNamara, D. B., et al., “Drugs Affecting Homocysteine Metabolism: Impact on Cardiovascular Risk,” Drugs, 62(4), 2002, pages 605–616.
Passaro, A., Calzoni, F., Volpato, S., et al., “Effect of Metabolic Control on Homocysteine Levels in Type 2 Diabetic Patients: A 3-Year Follow-Up,” Journal of Internal Medicine, 254(3), 2003, pages 264–271.
Mayer, O., Filipovsky, J., Hromadka, M., et al., “Treatment of Hyperhomocysteinemia with Folic Acid: Effects on Homocysteine Levels, Coagulation Status, and Oxidative Stress Markers,” Journal of Cardiovascular Pharmacology, 39(6), 2002, pages 851–857.
Lipsy, R. J., “Overview of Pharmacologic Therapy for the Treatment of Dyslipidemia,” Journal of Managed Care Pharmacy, 9(S1), 2003, pages 9–12.
Wang, W., Basinger, A., Neese, R. A., et al., “Effects of Nicotinic Acid on Fatty Acid Kinetics, Fuel Selection, and Pathways of Glucose Production in Women,” American Journal of Physiology, Endocrinology and Metabolism, 279(1), 2000, pages E50–59.
Prisco, D., Rogasi, P. G., Matucci, M., et al., “Effect of Oral Treatment with Pantethine on Platelet and Plasma Phospholipids in IIa Hyperlipoproteinemia,” Angiology, 38(3), 1987, pages 241–247.
Klevay, L. M., Milne, D. B., “Low Dietary Magnesium Increases Supraventricular Ectopy,” American Journal of Clinical Nutrition, 75(3), 2002, pages 550–554.
Rukshin, V., Shah, P. K., Cercek, B., et al., “Comparative Antithrombotic Effects of Magnesium Sulfate and the Platelet Glycoprotein IIb/IIIa Inhibitors Tirofiban and Eptifibatide in a Canine Model of Stent Thrombosis,” Circulation, 105(16), 2002, pages 1970–1975.
Rude, R., Manoogian, C., Ehrlich, L., et al., “Mechanisms of Blood Pressure Regulation by Magnesium in Man,” Magnesium, 8(5–6), 1989, pages 266–273.
Militante, J. D., Lombardini, J. B., “Treatment of Hypertension with Oral Taurine: Experimental and Clinical Studies,” Amino Acids, 23(4), 2002, pages 381–393.
Schaffer, S. W., Lombardini, J. B., Azuma, J., “Interaction between the Actions of Taurine and Angiotensin II,” Amino Acids, 18(4), 2000, pages 305–318.
Schuller-Levis, G. B., Park, E., “Taurine: New Implications for an Old Amino Acid,” FEMS Microbiology Letters, 226(2), 2003, pages 195–202.
Toft, I., Bonaa, K. H., Ingebretsen, O. C., et al., “Effects of N-3 Polyunsaturated Fatty Acids on Glucose Homeostasis and Blood Pressure in Essential Hypertension. A Randomized, Controlled Trial,” Annals of Internal Medicine, 123(12), 1995, pages 911–918.
Kris-Etherton, P. M., Harris, W. S., Appel, L. J., “Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, 23(2), 2003, pages e20–30.
Kris-Etherton, P. M., Harris, W. S., Appel, L. J., “Omega-3 Fatty Acids and Cardiovascular Disease: New Recommendations from the American Heart Association,” Arteriosclerosis, Thrombosis, and Vascular Biology, 23(2), 2003, pages 151–152.
Friedberg, C. E., Janssen, M. J., Heine, R. J., et al., “Fish Oil and Glycemic Control in Diabetes. A Meta-Analysis,” Diabetes Care, 21 (4), 1998, pages 494–500.
Lee, K. W., Lip, G. Y., “The Role of Omega-3 Fatty Acids in the Secondary Prevention of Cardiovascular Disease,” QJM, 96(7), 2003, pages 465–480.
Jackson, P. R., Wallis, E. J., Haq, I. U., et al., “Statins for Primary Prevention: At What Coronary Risk Is Safety Assured?” British Journal of Clinical Pharmacology, 52(4), 2001, pages 439–446.
Helmrich, S. P., Ragland, D. R., Leung, R. W., et al., “Physical Activity and Reduced Occurrence of Non-Insulin-Dependent Diabetes Mellitus,” New England Journal of Medicine, 325(3), 1991, pages 147–152.
Pan, X. R., Li, G. W., Hu, Y. H., et al., “Effects of Diet and Exercise in Preventing NIDDM in People with Impaired Glucose Tolerance. The Da Qing Igt and Diabetes Study,” Diabetes Care, 20(4), 1997, pages 537–544.
Boule, N. G., Haddad, E., Kenny, G. P., et al., “Effects of Exercise on Glycemic Control and Body Mass in Type 2 Diabetes Mellitus: A Meta-Analysis of Controlled Clinical Trials,” Journal of the American Medical Association, 286(10), 2001, pages 1218–1227.
Pate, R. R., Pratt, M., Blair, S. N., et al., “Physical Activity and Public Health. A Recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine,” Journal of the American Medical Association, 273(5), 1995, pages 402–407.
Myers, J., Prakash, M., Froelicher, V., et al., “Exercise Capacity and Mortality among Men Referred for Exercise Testing,” New England Journal of Medicine, 346( 11 ), 2002, pages 793–801.
Lee, I. M., Sesso, H. D., Oguma, Y., et al., “Relative Intensity of Physical Activity and Risk of Coronary Heart Disease,” Circulation, 107(8), 2003, pages 1110–1116.
Albert, C. M., Mittleman, M. A., Chae, C. U., et al., “Triggering of Sudden Death from Cardiac Causes by Vigorous Exertion,” New England Journal of Medicine, 343(19), 2000, pages 1355–1361.
Hu, F. B., Sigal, R. J., Rich-Edwards, J. W., et al., “Walking Compared with Vigorous Physical Activity and Risk of Type 2 Diabetes in Women: A Prospective Study,” Journal of the American Medical Association, 282(15), 1999, pages 1433–1439.
Centers for Disease Control and Prevention, CDC At a Glance: “Diabetes: Disabling, Deadly, and on the Rise 2004,” available at: http://www.cdc.gov/nccdphp/aag/pdf/aag_ddt2004.pdf, accessed on April 15, 2004.
American Heart Association, “Obesity and Overweight in Children,” available at: http://www.americanheart.org/presenter.jhtml?identifier=4670, accessed on April 15, 2004.
WHO Global Strategy on Diet, Physical Activity and Health, “Fact Sheet: Obesity and Overweight,” 2003, available at: http://www.who.int/hpr/NPH/docs/gs_obesity.pdf, accessed on April 20, 2004.
Halford, J. C., Gillespie, J., Brown, V., et al., “Food Advertisements Induce Food Consumption in Both Lean and Obese Children,” Obesity Research, 12(1), 2004, page 171.
Dwyer, J. T., Michell, P., Cosentino, C., et al., “Fat-Sugar See-Saw in School Lunches: Impact of a Low Fat Intervention,” Journal of Adolescent Health, 32(6), 2003, pages 428–435.
American Academy of Pediatrics Committee on School Health, “Soft Drinks in Schools,” Pediatrics, 113(1 Pt 1), 2004, pages 152–154.
Dews, P. B., O’Brien, C. P., Bergman, J., “Caffeine: Behavioral Effects of Withdrawal and Related Issues,” Food and Chemical Toxicology, 40(9), 2002, pages 1257–1261.
Ludwig, D. S., Peterson, K. E., Gortmaker, S. L., “Relation Between Consumption of Sugar-Sweetened Drinks and Childhood Obesity: A Prospective, Observational Analysis,” Lancet, 357(9255), 2001, pages 505–508.
Harnack, L., Stang, J., Story, M., “Soft Drink Consumption among US Children and Adolescents: Nutritional Consequences,” Journal of the American Dietetic Association, 99(4), 1999, pages 436–441.
Caballero, B., “Global Patterns of Child Health: The Role of Nutrition ,” Annals of Nutrition and Metabolism, 46 (11S), 2002, pages 3–7.
Wyshak, G., “Teenaged Girls, Carbonated Beverage Consumption, and Bone Fractures,” Archives of Pediatrics and Adolescent Medicine, 154(6), 2000, pages 610–613.
Nicklas, T., Johnson, R., “Position of the American Dietetic Association: Dietary Guidance for Healthy Children Ages 2 to 11 Years,” Journal of the American Dietetic Association, 104(4), 2004, pages 660–677.
Block, G., Smith, J., “New Nutrition Analysis Shows Results of Kids’ Simple Fruit and Vegetable Substitutions,” March 2002, available at: http://www.dole5aday.com/Media/Press/RecentReleases/031602.jsp?topmenu=5, accessed on April 21, 2004.
Giammattei, J., Blix, G., Marshak, H. H., et al., “Television Watching and Soft Drink Consumption: Associations with Obesity in 11-to 13-Year-Old Schoolchildren,” Archives of Pediatrics and Adolescent Medicine, 157(9), 2003, pages 882–886.
Guo, S. S., Wu, W., Chumlea, W. C., et al., “Predicting Overweight and Obesity in Adulthood from Body Mass Index Values in Childhood and Adolescence,” American Journal of Clinical Nutrition, 76(3), 2002, pages 653–658.
Whitaker, R. C., Wright, J. A., Pepe, M. S., et al., “Predicting Obesity in Young Adulthood from Childhood and Parental Obesity,” New England Journal of Medicine, 337(13), 1997, pages 869–873.
Ferraro, K. F., Thorpe, R. J., Jr., Wilkinson, J. A., “The Life Course of Severe Obesity: Does Childhood Overweight Matter?” Journals of Gerontology. Series B, Psychological Sciences and Social Sciences, 58(2), 2003, pages S1 10–119.
Gunnell, D. J., Frankel, S. J., Nanchahal, K., et al., “Childhood Obesity and Adult Cardiovascular Mortality: A 57-Y Follow-Up Study Based on the Boyd Orr Cohort,” American Journal of Clinical Nutrition, 67(6), 1998, pages 1111–1118.
Engeland, A., Bjorge, T., Sogaard, A. J., et al., “Body Mass Index in Adolescence in Relation to Total Mortality: 32-Year Follow-Up of 227,000 Norwegian Boys and Girls,” American Journal of Epidemiology, 157(6), 2003, pages 517–523.
Berenson, G. S., Wattigney, W. A., Tracy, R. E., et al., “Atherosclerosis of the Aorta and Coronary Arteries and Cardiovascular Risk Factors in Persons Aged 6 to 30 Years and Studied at Necropsy (the Bogalusa Heart Study),” American Journal of Cardiology, 70(9), 1992, pages 851–858.
Chu, N. F., Rimm, E. B., Wang, D. J., et al., “Clustering of Cardiovascular Disease Risk Factors Among Obese Schoolchildren: The Taipei Children Heart Study,” American Journal of Clinical Nutrition, 67(6), 1998, pages 1141–1146.
Sorof, J. M., Lai, D., Turner, J., et al., “Overweight, Ethnicity, and the Prevalence of Hypertension in School-Aged Children,” Pediatrics, 113(3 Pt 1), 2004, pages 475–482.
Cook, S., Weitzman, M., Auinger, P., et al., “Prevalence of a Metabolic Syndrome Phenotype in Adolescents: Findings from the Third National Health and Nutrition Examination Survey, 1988–1994,” Archives of Pediatrics and Adolescent Medicine, 157(8), 2003, pages 821–827.
Cruz, M. L., Weigensberg, M. J., Huang, T. T., et al., “The Metabolic Syndrome in Overweight Hispanic Youth and the Role of Insulin Sensitivity,” Journal of Clinical Endocrinology and Metabolism, 2004, 89(1), pages 108–13.
Sinha, R., Fisch, G., Teague, B., et al., “Prevalence of Impaired Glucose Tolerance Among Children and Adolescents with Marked Obesity,” New England Journal of Medicine, 346(11), 2002, pages 802–810.
von Mutius, E., Schwartz, J., Neas, L. M., et al., “Relation of Body Mass Index to Asthma and Atopy in Children: The National Health and Nutrition Examination Study III,” Thorax, 56(11), 2001, pages 835–838.
Edmunds, L., Waters, E., Elliott, E. J., “Evidence Based Pediatrics: Evidence Based Management of Childhood Obesity,” BMJ, 323(7318), 2001, pages 916–919.
Bray, G. A., “Obesity and Reproduction,” Human Reproduction, 12(1S), 1997, pages 26–32.
Franks, S., “Adult Polycystic Ovary Syndrome Begins in Childhood ,” Best Practice Research. Clinical Endocrinology &Metabolism, 16(2), 2002, pages 263–272.
Lewy, V. D., Danadian, K., Witchel, S. F., et al., “Early Metabolic Abnormalities in Adolescent Girls with Polycystic Ovarian Syndrome ,” Journal of Pediatrics, 138(1), 2001, pages 38–44.
Lumeng, J. C., Gannon, K., Cabral, H. J., et al., “Association Between Clinically Meaningful Behavior Problems and Overweight in Children,” Pediatrics, 2003, 112(5), pages 1138–1145.
Schwimmer, J. B., Burwinkle, T. M., Varni, J. W., “Health-Related Quality of Life of Severely Obese Children and Adolescents,” Journal of the American Medical Association, 2003, 289, pages 1813–1819.
Sondike, S. B., Copperman, N., Jacobson, M. S., “Effects of a Low-Carbohydrate Diet on Weight Loss and Cardiovascular Risk Factor in Overweight Adolescents,” Journal of Pediatrics, 2003, 142(3), pages 253–258.
American Diabetes Association, “Type 2 Diabetes in Children and Adolescents. American Diabetes Association,” Diabetes Care, 23(3), 2000, pages 381–389.
American Diabetes Association, “Type 2 Diabetes in Children and Adolescents. American Diabetes Association,” Diabetes Care, 23(3), 2000, pages 381–389.
Pinhas-Hamiel, O., Dolan, L. M., Daniels, S. R., et al., “Increased Incidence of Non-Insulin-Dependent Diabetes Mellitus among Adolescents,” Journal of Pediatrics, 128(5 Pt 1), 1996, pages 608–615.
Fagot-Campagna, A., Pettitt, D. J., Engelgau, M. M., et al., “Type 2. Diabetes among North American Children and Adolescents: An Epidemiologic Review and a Public Health Perspective,” Journal of Pediatrics, 136(5), 2000, pages 664–672.
Alberti, K. G., Zimmet, P. Z., “Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus Provisional Report of a WHO Consultation,” Diabetic Medicine, 15(7), 1998, pages 539–553.
American Diabetes Association, “Type 2 Diabetes in Children and Adolescents. American Diabetes Association,” Diabetes Care, 23(3), 2000, pages 381–389.
Kibirige, M., Metcalf, B., Renuka, R., et al., “Testing the Accelerator Hypothesis: The Relationship Between Body Mass and Age at Diagnosis of Type 1 Diabetes,” Diabetes Care, 26(10), 2003, pages 2865–2870.
Libman, I. M., Pietropaolo, M., Arslanian, S. A., et al., “Evidence for Heterogeneous Pathogenesis of Insulin-Treated Diabetes in Black and White Children,” Diabetes Care, 26(10), 2003, pages 2876–2882.
Dean, H., “Diagnostic Criteria for Non-Insulin Dependent Diabetes in Youth (NIDDM-Y),” Clinical Pediatrics, 37(2), 1998, pages 67–71.
National Institute of Diabetes and Digestive and Kidney Diseases. National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Bethesda, MD: U. S. Department of Health and Human Services, National Institutes of Health, 2003.
Waldhor, T., Schober, E., Rami, B., et al., “The Prevalence of IDDM in the First Degree Relatives of Children Newly Diagnosed with Iddm in Austria—a Population-Based Study. Austrian Diabetes Incidence Study Group,” Experimental and Clinical Endocrinology and Diabetes, 107(5), 1999, pages 323–327.
Redondo, M. J., Yu, L., Hawa, M., et al., “Heterogeneity of Type I Diabetes: Analysis of Monozygotic Twins in Great Britain and the United States,” Diabetologia, 44(3), 2001, pages 354–362.
American Diabetes Association, “Type 2 Diabetes in Children and Adolescents. American Diabetes Association,” Diabetes Care, 23(3), 2000, pages 381–389.
Jones, K. L., “Non-Insulin Dependent Diabetes in Children and Adolescents: The Therapeutic Challenge,” Clinical Pediatrics, 37(2), 1998, pages 103–110.
Stuart, C. A., Driscoll, M. S., Lundquist, K. F., et al., “Acanthosis Nigricans,” Journal of Basic and Clinical Physiology and Pharmacology, 9(2–4), 1998, pages 407–418.
Smith, C. P., Archibald, H. R., Thomas, J. M., et al., “Basal and Stimulated Insulin Levels Rise with Advancing Puberty,” Clinical Endocrinology, 28(1), 1988, pages 7–14.
Onyemere, K. U., Lipton, R. B., “Parental History and Early-Onset Type 2 Diabetes in African Americans and Latinos in Chicago,” Journal of Pediatrics, 141(6), 2002, pages 825–829.
Svensson, M., Sundkvist, G., Arnqvist, H. J., et al., “Signs of Nephropathy May Occur Early in Young Adults with Diabetes Despite Modern Diabetes Management: Results from the Nationwide Population-Based Diabetes Incidence Study in Sweden (DISS),” Diabetes Care, 26(10), 2003, pages 2903–2909.
Henricsson, M., Nystrom, L., Blohme, G., et al., “The Incidence of Retinopathy 10 Years after Diagnosis in Young Adult People with Diabetes: Results from the Nationwide Population-Based Diabetes Incidence Study in Sweden (DISS),” Diabetes Care, 26(2), 2003, pages 349–354.
Hillier, T. A., Pedula, K. L., “Complications in Young Adults with Early-Onset Type 2 Diabetes: Losing the Relative Protection of Youth,” Diabetes Care, 26(11), 2003, pages 2999–3005.
Hillier, T. A., Pedula, K. L., “Complications in Young Adults with Early-Onset Type 2 Diabetes: Losing the Relative Protection of Youth,” Diabetes Care, 26(11), 2003, pages 2999–3005.
Dean, H., Flett, B., “Natural History of Type 2 Diabetes Diagnosed in Childhood: Long-Term Follow-Up in Young Adult Years,” Diabetes, 51(S2), 2002, Abstract 99-OR, pages A24-A25.
Bray, G. A., “Obesity and Reproduction,” Human Reproduction, 12(S1), 1997, pages 26–32.